Literature DB >> 8394231

Atopic dermatitis--messengers, second messengers and cytokines.

C A Holden1.   

Abstract

Atopic dermatitis (AD) shows many complex and interacting abnormalities of pharmacology, immunology and cellular control. Recent research in atopy has concentrated on abnormalities of cytokine production by T-helper cells. It is possible that cytokine imbalance causes many of the pharmacological and immunological changes seen in the disease. However, studies of second messenger control of cytokine release show that different second messenger signals may relate to the release and activation of particular cytokines. This review summarizes these findings and discusses how the second messenger defects reported in AD may relate to the abnormal cytokine profiles and the pharmacological abnormalities seen in the condition.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8394231     DOI: 10.1111/j.1365-2230.1993.tb02171.x

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


  2 in total

1.  Increase in macrophage migration inhibitory factor levels in lacrimal fluid of patients with severe atopic dermatitis.

Authors:  Nobuyoshi Kitaichi; Tadamichi Shimizu; Ayumi Honda; Riichiro Abe; Kazuhiro Ohgami; Kenji Shiratori; Hiroshi Shimizu; Shigeaki Ohno
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-12-06       Impact factor: 3.117

2.  Impaired Toll-like receptor 2-mediated Th1 and Th17/22 cytokines secretion in human peripheral blood mononuclear cells from patients with atopic dermatitis.

Authors:  Yangyang Yu; Yarui Zhang; Jie Zhang; Xia Dou; Hong Yang; Yong Shao; Kepeng Wang; Bo Yu; Wei Zhang; Hang Yung Alaster Lau
Journal:  J Transl Med       Date:  2015-12-18       Impact factor: 5.531

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.